author-photo

Anne-Marie Kirsten

PAREXEL

12

Papers

144

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD

2017 Pulmonary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (50)
Efficacy of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in COPD

2016 Pneumologie
Show All
- Source
- Cite
- Save
Citations (0)
Wirksamkeit und Sicherheit von Indacaterol/Mometason (1x/Tag) verglichen mit Salmeterol/Fluticason (2x/Tag) bei Patienten mit mäßiger bis sehr schwerer COPD

2015 Pneumologie
Show All
- Source
- Cite
- Save
Citations (0)
P251 Efficacy And Safety Of Once-daily Indacaterol/mometasone Compared With Twice-daily Salmeterol/fluticasone In Patients With Moderate To Very Severe Copd

2014 Thorax
Show All
- Source
- Cite
- Save
Citations (0)
Corrigendum to “A randomised, placebo- and active-controlled dose-finding study of aclidinium bromide administered twice a day in COPD patients” [Pulm Pharmacol Ther 25 (3) (2012) 248–253]

2013 Pulmonary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (3)
Effekt von Aclidiniumbromid im Vergleich zu Tiotropium und Placebo auf Bronchodilatation und Symptome bei Patienten mit moderater bis schwerer COPD; eine Phase IIIb Studie

2013 Pneumologie
Show All
- Source
- Cite
- Save
Citations (0)
Effect of fissure integrity on lung volume reduction using a polymer sealant* in advanced emphysema

2012 Thorax
Show All
- Source
- Cite
- Save
Citations (52)
A randomised, placebo- and active-controlled dose-finding study of aclidinium bromide administered twice a day in COPD patients.

2012 Pulmonary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (35)
P256 Aclidinium bromide: a Phase IIb, dose-finding study

2011 Thorax
Show All
- Source
- Cite
- Save
Citations (2)
Efficacy and Safety of Twice-Daily Aclidinium Bromide 400 μ g Compared With Placebo and Tiotropium 18 μ g QD in Moderate to Severe COPD Patients

2010 Chest
Show All
- Source
- Cite
- Save
Citations (2)